Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Particulate & foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables.

867 FDA drug recalls with this cause, newest first.

These recalls involve visible foreign material - glass, metal, fibers, rubber or other debris - most often found in injectable or liquid products, where nothing besides the intended ingredients should be present. It also includes foreign tablets or capsules found in a bottle of a different product. In an injectable a stray particle can go straight into the bloodstream, which is why a noticeable share of these recalls are Class I.

Class III · Low risk

Sodium Chloride Ophthalmic Ointment USP

Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.

Terminated Particulate / foreign matter Akorn, Inc. NDC 17478-622-35 D-0859-2020
Class II · Moderate risk

Major Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 0904-6730-60 D-0858-2020
Class II · Moderate risk

Leader Extra Strength Acetaminophen Tablets

Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.

Terminated Particulate / foreign matter Contract Pharmacal Corporation NDC 7000-0036-1 D-0857-2020
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.

Terminated Particulate / foreign matter Graviti Pharmaceuticals Private Limited NDC 70377-027-11 D-0832-2020
Class I · High risk

Ketorolac Trom

Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.

Terminated Particulate / foreign matter RemedyRepack Inc. NDC 70518-1239-00 D-0867-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Preferred Pharmaceuticals, Inc NDC 68788-7268-01 D-0531-2020
Class II · Moderate risk

Gabapentin Capsules

Presence of Foreign Tablets/Capsules: One Losartan/HCTZ tablet was found in Gabapentin 1000 count bottles..

Terminated Particulate / foreign matter AuroMedics Pharma LLC NDC 65682-198-99 D-0653-2020
Class II · Moderate risk

fentaNYL 550 mcg/55 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1274-50 D-0572-2020
Class II · Moderate risk

fentaNYL 1500 mcg/30 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1180-79 D-0570-2020
Class II · Moderate risk

fentaNYL 2500 mcg/50 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1436-76 D-0569-2020
Class II · Moderate risk

fentaNYL 800 mcg/200 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1436-76 D-0568-2020
Class II · Moderate risk

fentaNYL 1000 mcg/20 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1415-47 D-0566-2020
Class II · Moderate risk

fentaNYL 200 mcg/100 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1103-36 D-0565-2020
Class II · Moderate risk

fentaNYL 400 mcg/200 mL

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Terminated Particulate / foreign matter QuVa Pharma, Inc. NDC 70092-1441-76 D-0564-2020